Zeba Sultana

PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance

Feda Azab, Shireen Vali, Joseph P. Abraham et al. · British Journal of Haematology · 2014 · 41 citations

Medicine, Oncology, Pharmacology +17

In silico modeling predicts drug sensitivity of patient-derived cancer cells

Sandeep C. Pingle, Zeba Sultana, Sandra Pastorino et al. · Journal of Translational Medicine · 2014 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +17

Personalization of cancer treatment using predictive simulation

Nicole Doudican, Ansu Kumar, Neeraj Singh et al. · Journal of Translational Medicine · 2015 · 26 citations · Full text

Medicine, Cancer Biology, Oncology +17

Dynamic modeling of α-synuclein aggregation in dopaminergic neuronal system indicates points of neuroprotective intervention: experimental validation with implications for Parkinson's therapy

Zeba Sultana, Katerina E. Paleologou, Karima M. Al-Mansoori et al. · Neuroscience · 2011 · 22 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Insights into the effects of α-synuclein expression and proteasome inhibition on glutathione metabolism through a dynamic in silico model of Parkinson's disease: validation by cell culture data

Shireen Vali, Shankar J. Chinta, Jie Peng et al. · Free Radical Biology and Medicine · 2008 · 20 citations · Full text

Life Sciences, Biochemistry, Neuroscience +16